Age, independent from ovarian reserve status, is the main prognostic factor in natural cycle in vitro fertilization
Natural cycle in vitro fertilization results depend on patient age but not on ovarian reserve status, cause of infertility, or modification of the cycle with the use of gonadotropin-releasing hormone antagonist.
Volume 106, Issue 2, Pages 342-347
Authors:
Iñaki González-Foruria, M.D., Juana Peñarrubia, M.D., Aina Borràs, M.D., Dolors Manau, M.D., Gemma Casals, M.D., Sara Peralta, M.D., Montserrat Creus, M.D., Janisse Ferreri, M.D., Ester Vidal, Ph.D., Francisco Carmona, M.D., Juan Balasch, M.D., Francisco Fàbregues, M.D.
Abstract:
Objective
To analyze natural cycle IVF (NC-IVF) results according to patient age, ovarian reserve status following the Bologna criteria, cause of infertility, and modification of the cycle with the use of GnRH antagonist.
Design
Retrospective cohort study.
Setting
Tertiary-care university hospital.
Patient(s)
Nine hundred forty-seven natural cycles carried out in 320 patients.
Intervention(s)
Analysis of 947 NC-IVF outcomes performed in one single center between January 2010 and December 2014.
Main Outcome Measure(s)
Pregnancy rates per cycle started, per ET, and per patient, as well as ongoing pregnancy rate at a minimum of 12 weeks of gestation.
Result(s)
Among the three age groups analyzed (≤35 years, 36–39 years, and ≥40 years), pregnancy rates per cycle were significantly lower in the older group of patients (11.4% vs. 11.6% vs. 5.9%). In addition, miscarriage rate (7.7% vs. 34.4% vs. 50%) and ongoing pregnancy rate (10.6% vs. 7.6%vs. 3.0%) were negatively affected by patient age. However, no differences were observed according to patient ovarian reserve status, cause of infertility, or modification of the cycle with GnRH antagonist. The multivariate logistic regression confirmed that patient age was the only variable that could predict pregnancy in NC-IVF cycles (odds ratio, 0.93; 95% confidence interval, 0.88–0.98).
Conclusion(s)
NC-IVF is a feasible and “patient-friendly” option to be offered to young patients, independent of their ovarian reserve status.
No comments yet.